MYMX Mymetics Corporation

Mymetics Corp. is a biotechnology company, which engages in the research and development of virosome based vaccines. It focuses on next generation vaccines for infectious and life disabling diseases. The company was founded in July 1994 and is headquartered in Epalinges, Switzerland.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.03    OTCQB
As of 01/26/2022     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Switzerland
Country of incorporation:  
IPO date:  04/03/2000
Outstanding shares:  303,757,622
Average volume:  69,699
Market cap:   $8,717,844
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -2.75
PB ratio:   -0.16
PS ratio:   -76.37
Return on equity:   7.52%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy